Edit
OncoMed
http://www.oncomed.com/Last activity: 05.01.2018
Active - Reference to Mereo BioPharma
Developer of anti-cancer therapeutics
Location: Canada
Employees: 11-50
Total raised: $126.12M
Founded date: 2004
Investors 2
| Date | Name | Website |
| - | Adams Stre... | adamsstree... |
| - | Delphi Ven... | delphivent... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.11.2008 | - | $93M | - |
| 30.08.2006 | - | $33.12M | - |
Mentions in press and media 7
| Date | Title | Description |
| 05.01.2018 | Sanuj Ravindran to lead PellePharm as CEO; Paul Hastings leaves OncoMed; Moderna taps John Mendlein as president | Sanuj Ravindran → A new president and CEO, Sanuj Ravindran, will lead PellePharm into this year’s Phase III trial for its skin cancer drug. PellePharm, which specializes in rare genetic dermatological conditions, has re... |
| 30.01.2017 | Healthcare industry weighs in on Trump’s travel ban | The sentiment harkens back to the stance that several life science companies took against state efforts to limit definitions of marriage to that between a man and a woman. That diversity is actually good for business so anything contrary to... |
| 21.03.2012 | The JOBS Act: Support Growing Biotech Companies Developing Breakthrough Medicines | Editor’s note: William D. Waddill is the Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals. Small biotechnology companies are leading innovation across the country. My company, OncoMed Pharmaceuticals, is working ... |
| 04.11.2008 | OncoMed nabs $93M for stem cell programs | OncoMed Pharmaceuticals, a company working to fight cancer using stem cells, added a $93 million tranche to a second round of funding that now totals $154 million. The money will be used to push its lead antibody candidate through phase-two... |
| 11.12.2007 | Life sciences briefing: Tuesday, Dec. 11, 2007 | TODAY’S HEADLINES: Cancer stem-cell co. OncoMed strikes GSK partnership worth up to $1.4B (release) Kosmix pulls in $10M for health, lifestyle search (release) CDI Bioscience pulls in $3M for protein-production improvements (release) UroMed... |
| 30.08.2006 | OncoMed Pharmaceuticals raises $33.12 million | OncoMed Pharmaceuticals Inc., of Mountain View, has raised $33.12 million in Series B funding, according to a regulatory filing. Adams Street Partners was joined by return backers like Latterell Venture Partners, Morgenthaler Ventures, U.S.... |
| - | Healthcare industry weighs in on Trump’s travel ban | Protesters are seen during a rally to protest the executive order that President Donald Trump signed clamping down on refugee admissions and temporarily restricting travelers from seven predominantly Muslim countries in New York City on Jan... |